Quarterly report · Q1
3353.TEDINET S100REIO
Period2023-03-01 → 2023-05-31
Filed2023-07-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.7bn | 2023-03-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥33.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.6bn | 2022-03-01 → 2022-05-31 | Cons. | Net sales |
| Operating income | ¥294m | 2023-03-01 → 2023-05-31 | Cons. | Operating income |
| Operating income | ¥239m | 2022-03-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥338m | 2023-03-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥313m | 2022-03-01 → 2022-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥375m | 2023-03-01 → 2023-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥334m | 2022-03-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥212m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥760m | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥208m | 2022-03-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥224m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss |
| Net income | ¥213m | 2022-03-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥28.1bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥27.5bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥28.8bn | at 2022-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.4bn | at 2023-05-31 | Cons. | Liabilities |
| Total liabilities | ¥14.9bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥12.7bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥12.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥12.0bn | at 2022-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| EPS (basic) | ¥56.42 | 2023-03-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥202.2 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.39 | 2022-03-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 43.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.8% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-05-31 | −¥187m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥375m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥50m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥1.1bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥810m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥275m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥23m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥47m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥46m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥1m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-03-01 → 2023-05-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-03-01 → 2023-05-31 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥277m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-03-01 → 2023-05-31 | ¥481m |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-05-31 | −¥253m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-05-31 | −¥253m |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-05-31 | −¥189m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥363m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥19m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥946m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥694m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥252m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥16m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥49m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥49m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥381,000 |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥30m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-03-01 → 2022-05-31 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-03-01 → 2022-05-31 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥253m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-03-01 → 2022-05-31 | ¥428m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 355
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration | 239051000 | JPY |
| Operating income | CurrentYTDDuration | 294402000 | JPY |
| Interest income noi | Prior1YTDDuration | 309000 | JPY |
| Interest income noi | CurrentYTDDuration | 308000 | JPY |
| Dividends income noi | Prior1YTDDuration | 442000 | JPY |
| Dividends income noi | CurrentYTDDuration | 1505000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 31642000 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 51295000 | JPY |
| Gain on reversal of advance received noi | Prior1YTDDuration | 48528000 | JPY |
| Gain on reversal of advance received noi | CurrentYTDDuration | － | JPY |
| Other noi | Prior1YTDDuration | 6458000 | JPY |
| Other noi | CurrentYTDDuration | 8337000 | JPY |
| Non operating income | Prior1YTDDuration | 87381000 | JPY |
| Non operating income | CurrentYTDDuration | 61446000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 13659000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 12479000 | JPY |
| Other noe | Prior1YTDDuration | 123000 | JPY |
| Other noe | CurrentYTDDuration | 5355000 | JPY |
| Non operating expenses | Prior1YTDDuration | 13783000 | JPY |
| Non operating expenses | CurrentYTDDuration | 17835000 | JPY |
| Ordinary income | Prior1YTDDuration | 312649000 | JPY |
| Ordinary income | CurrentYTDDuration | 338014000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 20497000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | － | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 429000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 36737000 | JPY |
| Subsidy ei | Prior1YTDDuration | － | JPY |
| Subsidy ei | CurrentYTDDuration | 2480000 | JPY |
| Extraordinary income | Prior1YTDDuration | 20926000 | JPY |
| Extraordinary income | CurrentYTDDuration | 39217000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 0 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 205000 | JPY |
| Loss on reduction of noncurrent assets el | Prior1YTDDuration | － | JPY |
| Loss on reduction of noncurrent assets el | CurrentYTDDuration | 2480000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 0 | JPY |
| Extraordinary loss | CurrentYTDDuration | 2685000 | JPY |
| Income before income taxes | Prior1YTDDuration | 333576000 | JPY |
| Income before income taxes | CurrentYTDDuration | 374546000 | JPY |
| Income taxes current | Prior1YTDDuration | 145537000 | JPY |
| Income taxes current | CurrentYTDDuration | 219705000 | JPY |
| Income taxes deferred | Prior1YTDDuration | -25048000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -69060000 | JPY |
| Income taxes | Prior1YTDDuration | 120489000 | JPY |
| Income taxes | CurrentYTDDuration | 150645000 | JPY |
| Profit loss | Prior1YTDDuration | 213087000 | JPY |
| Profit loss | CurrentYTDDuration | 223900000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 5023000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 11927000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 208063000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 211973000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |